| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.21B | 6.33B | 5.33B | 4.54B | 4.05B |
| Gross Profit | 2.19B | 1.94B | 1.59B | 1.27B | 1.09B |
| EBITDA | 669.65M | 593.12M | 452.48M | 337.35M | 311.59M |
| Net Income | 436.03M | 357.57M | 228.08M | 162.64M | 136.91M |
Balance Sheet | |||||
| Total Assets | 6.25B | 5.71B | 5.06B | 5.01B | 5.39B |
| Cash, Cash Equivalents and Short-Term Investments | 2.32B | 1.94B | 1.31B | 1.42B | 1.51B |
| Total Debt | 995.84M | 593.06M | 518.11M | 933.40M | 876.51M |
| Total Liabilities | 3.70B | 3.39B | 2.73B | 2.83B | 3.07B |
| Stockholders Equity | 2.55B | 2.29B | 2.26B | 2.11B | 2.19B |
Cash Flow | |||||
| Free Cash Flow | 336.07M | 917.73M | 406.68M | 58.60M | 220.24M |
| Operating Cash Flow | 379.17M | 949.34M | 460.37M | 147.10M | 273.99M |
| Investing Cash Flow | -247.52M | -217.99M | -135.96M | -128.98M | -96.21M |
| Financing Cash Flow | 44.24M | -365.86M | -561.08M | -30.61M | 11.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$3.25B | 7.50 | 16.02% | 6.09% | 18.65% | 18.40% | |
72 Outperform | HK$211.94M | 7.60 | 8.42% | 18.18% | -7.56% | -2.06% | |
62 Neutral | HK$182.40M | 7.19 | -23.30% | 8.60% | -26.30% | -617.37% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | HK$460.00M | -162.21 | -5.38% | 1.90% | 3.04% | -22.93% | |
57 Neutral | HK$29.60M | 9.73 | 3.02% | ― | -6.40% | ― | |
53 Neutral | HK$801.77M | -10.57 | -2.27% | 13.04% | -11.14% | -280.56% |